[Effectiveness and safety of a new combined oral contraceptive containing 75 micrograms gestodene and 30 micrograms ethinyl estradiol in Mexican women].
Martinez
M
M
Perez Palacios
G
G
Garza Flores
J
J
Bassol
S
S
Recio
R
R
D000569:Americas; D001695:Biology; D002784:Cholesterol; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003906:Developing Countries; D005193:Family Planning Services; D006805:Human Experimentation; D007843:Latin America; D008055:Lipids; D008800:Mexico; D009656:North America; D010827:Physiology; D011446:Prospective Studies; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D008055:Lipids; D002784:Cholesterol
Americas; Biology; Cholesterol; Clinical Research; Contraception; Contraception Termination; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods; Developing Countries; Family Planning; Gestodene--side effects; Human Volunteers--women; Latin America; Lipid Metabolic Effects; Lipids; Mexico; North America; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Physiology; Prospective Studies; Research Methodology; Studies